NCT04747821View on ClinicalTrials.gov

An Effectiveness Study of the Sinovac's Adsorbed COVID-19 (Inactivated) Vaccine

PHASE4CompletedINTERVENTIONAL
Enrollment

27,711

Participants

Timeline

Start Date

February 7, 2021

Primary Completion Date

March 7, 2023

Study Completion Date

July 20, 2023

Conditions
Covid19
Interventions
BIOLOGICAL

Adsorbed COVID-19 (Inactivated) Vaccine

Adsorbed COVID-19 (inactivated) Vaccine manufactured by Sinovac

Trial Locations (1)

14150-000

Hospital Estadual de Serrana, Serrana

Sponsors

Lead Sponsor

Butantan Institute
All Listed Sponsors
lead

Butantan Institute

OTHER_GOV